Compare Hims and Hers Health Inc (HIMS) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Quantumscape Corp — how do they compare? Hims and Hers Health Inc trades at $30.48 (market cap $7.12B), while Quantumscape Corp trades at $6.34 (market cap $3.90B). The key difference: Hims and Hers Health Inc is the larger of the two by market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals.
| HIMS | QS | |
|---|---|---|
Market Cap | $7.12B | $3.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $62.76 | $18.44 |
52-Week Low | $14.52 | $4.89 |
Enterprise Value | $7.82B | $3.11B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $30.00, down 5.57% amid mixed Q2 2026 results. Revenue growth remains strong, with a 2026 outlook raised to $3.1B-$3.3B, but profitability is pressured by margin compression and a wider-than-expected quarterly loss. Technical indicators are neutral to bearish, with the price near key support at $30. Recent news highlights an FTC investigation and class-action lawsuits as headwinds.
The investment outlook is cautious. Growth prospects from subscriber gains and AI integration are offset by significant margin challenges and regulatory risks. Analyst consensus is a Hold with a $33.00 price target, suggesting limited near-term upside amid profitability concerns and negative free cash flow trends.
QuantumScape trades at $6.34, up 2.42% today, with a bullish technical signal but mixed sentiment. The company remains pre-revenue, reporting a net loss of $435.05M in 2025, with negative ROE and ROA. Recent earnings showed beats on EPS estimates, but commercialization timelines have been delayed to 2029, fueling investor skepticism.
The outlook hinges on successful battery technology commercialization by 2029, presenting high-risk, high-reward potential. Key risks include execution delays, intense competition, and reliance on financing. Analyst consensus is cautious, with no buy ratings, reflecting significant uncertainty around the company's path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
